146 related articles for article (PubMed ID: 18345034)
1. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy.
Eelen G; Vanden Bempt I; Verlinden L; Drijkoningen M; Smeets A; Neven P; Christiaens MR; Marchal K; Bouillon R; Verstuyf A
Oncogene; 2008 Jul; 27(30):4233-41. PubMed ID: 18345034
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
[TBL] [Abstract][Full Text] [Related]
5. BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study.
Frank B; Hemminki K; Meindl A; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
BMC Cancer; 2007 May; 7():83. PubMed ID: 17504528
[TBL] [Abstract][Full Text] [Related]
6. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
7. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H
Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423
[TBL] [Abstract][Full Text] [Related]
8. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
[TBL] [Abstract][Full Text] [Related]
9. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.
Litman R; Peng M; Jin Z; Zhang F; Zhang J; Powell S; Andreassen PR; Cantor SB
Cancer Cell; 2005 Sep; 8(3):255-65. PubMed ID: 16153896
[TBL] [Abstract][Full Text] [Related]
10. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
Ameziane N; van den Ouweland AM; Adank MA; Vijzelaar RN; Errami A; Dorsman JC; Joenje H; Meijers-Heijboer H; Waisfisz Q
Breast Cancer Res Treat; 2009 Dec; 118(3):651-3. PubMed ID: 19504183
[No Abstract] [Full Text] [Related]
11. A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function.
De Nicolo A; Tancredi M; Lombardi G; Flemma CC; Barbuti S; Di Cristofano C; Sobhian B; Bevilacqua G; Drapkin R; Caligo MA
Clin Cancer Res; 2008 Jul; 14(14):4672-80. PubMed ID: 18628483
[TBL] [Abstract][Full Text] [Related]
12. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer.
Reimer D; Sadr S; Wiedemair A; Goebel G; Concin N; Hofstetter G; Marth C; Zeimet AG
Ann N Y Acad Sci; 2006 Dec; 1091():270-81. PubMed ID: 17341621
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of E2F-1 and Rb expression with papillomatosis and ductal carcinoma in situ of the breast].
Niu Y; Li Y; Niu RF; Lü AJ; Fu XL
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):290-3. PubMed ID: 15312366
[TBL] [Abstract][Full Text] [Related]
14. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
15. Expression of retinoblastoma protein in human breast cancer: an immunohistochemical study.
Bianchi S; Calzolari A; Giannelli E; Giordano A; Zampi G
Pathologica; 1994 Apr; 86(2):146-9. PubMed ID: 7936756
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.
Cantor SB; Guillemette S
Future Oncol; 2011 Feb; 7(2):253-61. PubMed ID: 21345144
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
Bindra RS; Gibson SL; Meng A; Westermark U; Jasin M; Pierce AJ; Bristow RG; Classon MK; Glazer PM
Cancer Res; 2005 Dec; 65(24):11597-604. PubMed ID: 16357170
[TBL] [Abstract][Full Text] [Related]
18. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Seal S; Thompson D; Renwick A; Elliott A; Kelly P; Barfoot R; Chagtai T; Jayatilake H; Ahmed M; Spanova K; North B; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Nov; 38(11):1239-41. PubMed ID: 17033622
[TBL] [Abstract][Full Text] [Related]
19. Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.
Rizeq B; Sif S; Nasrallah GK; Ouhtit A
J Cell Mol Med; 2020 Oct; 24(19):11477-11488. PubMed ID: 32888398
[TBL] [Abstract][Full Text] [Related]
20. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW
Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]